Gastrointestinal Eosinophilic Diseases Program (GEDP) is dedicated to providing outstanding care for patients with eosinophilic gastrointestinal diseases (EGIDs) and investigating the eosinophil’s role in the gastrointestinal tract.
The GEDP is composed of two programs - research and clinical - that strive to develop innovative approaches towards the care and research of eosinophilic diseases.
CLINICAL SERVICES - Gastrointestinal Eosinophilic Diseases Program (GEDP) Provides state-of-the-art clinical care to patients affected by EGIDs, including eosinophilic esophagitis. »
RESEARCH - Gastrointestinal Eosinophil Research Program (GERP)
Performs novel research focusing on eosinophil's impact on the GI tract. »